欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/0114/003
药品名称
Lozap 50 Zentiva
活性成分
Losartan 12.5 mg
剂型
Tablet
上市许可持有人
Zentiva a.s., Bratislava Einsteinova 24 851 01 Bratislava Slovak Republic
参考成员国 - 产品名称
Czechia (CZ)
互认成员国 - 产品名称
Poland (PL)
Lozap 50
Latvia (LV)
Lozap 50 mg apvalkotās tabletes
Lithuania (LT)
Lozap 50 mg plėvele dengtos tabletės
Hungary (HU)
Slovakia (SK)
Losartan Zentiva 50 mg filmom obalené tablety
Estonia (EE)
许可日期
2005/12/21
最近更新日期
2025/01/20
药物ATC编码
C09CA01 losartan
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic [Article 10.1.(a)(iii), first paragraph]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
CZ_H_0114_01_03_E_01_LAB_Lozap 50
Date of last change:2024/09/06
Final PL
|
CZ_H_0114_01_03_E_01_PIL_Lozap
Date of last change:2024/09/06
Final Product Information
|
LOSARTAN POTASSIUM_film_coated tablet_EN_CZ_H_0114_001_003_004_orig_221204cl
Date of last change:2024/09/06
Final SPC
|
Lozap SPC _ Day 90
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase